Abstract: A method of preventing and/or treating a cancer including co-administering a c-Met inhibitor and a beta-catenin inhibitor to a subject in need thereof, a pharmaceutical composition comprising a c-Met inhibitor and a beta-catenin inhibitor, and a kit comprising a pharmaceutical composition comprising a c-Met inhibitor, and a pharmaceutical composition comprising a beta-catenin inhibitor packaged together.

Abstract: A method of preventing and/or treating a cancer including co-administering a c-Met inhibitor and a c-Myc Inhibitor to a subject in need thereof, a pharmaceutical composition comprising a c-Met inhibitor and a c-Myc inhibitor, and a kit comprising a pharmaceutically effective amount of a c-Met inhibitor as an active ingredient, and a second pharmaceutical composition comprising a pharmaceutically effective amount of a c-Myc inhibitor as an active ingredient, packaged together.

Abstract: Example embodiments relate to a manufacturing device of an anti-reflecting structure and a method for manufacturing the anti-reflecting structure. The manufacturing device of an anti-reflecting structure includes a carrier film on which a stamp structure is formed, an unwinding unit which unwinds the carrier film, a substrate support unit which provides a target substrate to the carrier film, a pressing unit which applies pressure to the carrier film so that a resin provided in the stamp structure is provided to the target substrate, and a winding unit which winds the carrier film from which an anti-reflecting pattern is transferred to the target substrate, wherein the pressing unit includes a chamber which stores the target substrate, and a vent hole formed in the chamber, and air within the chamber is discharged through the vent hole to lower the air pressure in the chamber and apply pressure to the carrier film.

Abstract: Disclosed therein is a rotor for a motor. The rotor includes: a rotor core including an annular ring having a shaft hole formed at a central portion thereof, a plurality of yokes formed around the annular ring, and magnet insertion holes formed between the neighboring yokes; magnets respectively inserted into the magnet insertion holes; and a pair of rotor covers each having a ring plate, which has a shaft insertion hole formed at a central portion thereof, and a plurality of stoppers protrudingly formed around the ring plate. A pair of the rotor covers are joined to an upper portion and a lower portion of the rotor core in such a fashion that the stoppers are respectively located at side portions of the magnet insertion holes.

Abstract: A motor assembly for a washing machine including: a stator core having teeth formed along the outer peripheral surface; upper and lower insulators coupled to the upper and lower portions of the stator core to surround the top and underside of the stator core; a first fastening rib protruding from the inner peripheral surface of the lower insulator; a second fastening rib protruding from the inner peripheral surface of the upper insulator to be coupled on the underside thereof to the top of the first fastening rib; and a round-shaped third fastening rib having the underside coupled to the top of the second fastening rib and the top protruding from the top of the upper insulator to be coupled to the underside of a housing in which various parts such as a brake drum and the like are mounted.

Abstract: A method of preventing and/or treating a cancer, the method including co-administering a dual inhibitor of c-Met (hereinafter, ‘c-Met inhibitor’) and an IGF-1R inhibitor to a subject in need thereof and a use of IGF-1R as a marker for resistance to a c-Met inhibitor.

Abstract: The present invention relates to a stator for a motor including: a stator core having a circular base along which a plurality of first holes is formed vertically and a plurality of teeth formed radially around the outer peripheral surface of the base; and an insulating layer coated on the entire surface of the stator core except the inner peripheral surface of the base and the plurality of first holes of the base.

Abstract: A polypeptide, an anti-VEGF antibody and an anti-c-Met/anti-VEGF bispecific antibody, which includes the polypeptide, a pharmaceutical composition including the antibody, and a method of treating cancer using the antibody.

Abstract: An anti-c-Met/anti-Ang2 bispecific antibody including (a) an anti-c-Met antibody or antigen-binding fragment thereof and (b) an anti-Ang2 antibody or antigen-binding fragment thereof, a pharmaceutical composition including the anti-c-Met/anti-Ang2 bispecific antibody, and a method using the anti-c-Met/anti-Ang2 bispecific antibody.

Abstract: A biomarker PNCK for predicting an efficacy of a dual-targeting agent that targets both c-Met and EGFR and a method of predicting an effect of a dual-targeting agent that targets both c-Met and EGFR, selecting the subject for application of a dual-targeting agent that targets both c-Met and EGFR, or monitoring an effect of a dual-targeting agent that targets both c-Met and EGFR, including measuring a level of a PNCK and/or a PNCK coding gene.

Abstract: A biomarker Hsp90 for predicting an efficacy of a c-Met inhibitor, selecting a subject for application of a c-Met inhibitor, or monitoring an efficacy of a c-Met inhibitor, and a relevant method of using Hsp90.

Abstract: A driving apparatus for a washing machine including: a housing; a brake drum rotatably disposed inside the housing; a dewatering shaft coupled to the brake drum; a washing shaft rotatably disposed inside the dewatering shaft; a rotor to which the washing shaft is coupled; a stator disposed inside the rotor; a brake lever disposed on the outer peripheral surface of the housing and adapted to operate a brake pad connected to one end thereof to control the rotation of the brake drum; a coupling clutch moved upwardly and downwardly along a lower end portion of the dewatering shaft; a clutch lever mounted on the housing and rotating upon the rotation of the brake lever to move the coupling clutch upwardly and downwardly; and a pressurizing lever coupled to the brake lever to rotate together with the brake lever and to push and rotate the clutch lever.

Abstract: Provided is a method of combination therapy for prevention or treatment of a cancer including or consisting essentially of co-administering sorafenib and an anti-c-Met antibody or an antigen-binding fragment thereof to a subject. The method of combination therapy can achieve an excellent synergistic effect and lower the effective dose of the anti-c-Met antibody, thereby enabling a more effective cancer treatment.

Abstract: Disclosed herein are novel electrochromic materials. The electrochromic materials produce various colors and have bistability to achieve red-green-blue full colors. Therefore, the electrochromic materials can be used in a variety of electrochromic devices. Also disclosed herein are electrochromic devices fabricated using the electrochromic materials.

Abstract: An electronic device, a method, and a chip set are provided. The electronic device includes a memory configured to store at least one of audio feature data of audio data and speech recognition data obtained by speech recognition of audio data; and a control module connected to the memory, wherein the control module is configured to update a voice command that is set to execute a function through voice, the function being selected based on at least one of the audio feature data, the speech recognition data, and function execution data executed in relation to the audio data.

Abstract: A method of identifying a cell sample or subject suitable for treatment with an anti-c-Met antibody or antigen-binding fragment thereof that specifically binds to an epitope within a SEMA domain of a c-Met protein by determining the presence of LRIG1 in a cell sample from the subject, as well as related methods and compositions.

Abstract: A method of identifying a cell sample or a subject suitable for treatment with an anti-c-Met antibody or antigen binding fragment thereof that specifically binds to an epitope within a SEMA domain of a c-Met protein by determining a Cbl concentration, a Cbl mutation, and/or a mutation of a site of c-Met for interaction with Cbl in a cell sample from a subject, as well as related compositions and methods.

Abstract: Provided is a method for prevention or treatment of a cancer, comprising co-administering (a) an FGFR inhibitor and (b) an anti-c-Met antibody or antigen-binding fragment thereof to a subject in need thereof, wherein the anti-c-Met antibody or the antigen-binding fragment thereof specifically binds to an epitope comprising 5 or more contiguous amino acids within the SEMA domain of c-Met protein.

Abstract: The present invention relates to a stator assembly that includes: a stator core having a circular base, a plurality of teeth radially formed along an outer circumference of the base, and at least one coupling bushing formed along an inner circumference of the base; an insulation coating layer formed on an surface of the stator core; and a pair of base insulators coupled to top and bottom portions of the base, respectively.

Abstract: An electro-optic modulator includes an electro-optic sensor layer including a liquid crystal stabilized by a polymer network having a three-dimensional mesh structure that extends from a first surface of the electro-optic sensor layer to second surface of the electro-optic sensor layer opposite the first surface, a transparent electrode layer on the first surface of the electro-optic sensor layer, and a reflective layer on the second surface of the electro-optic sensor layer. A thin film transistor (TFT) array test apparatus includes a light source, an electro-optic modulator including an electro-optic sensor layer formed of a polymer network liquid crystal (PNLC), a power supply that applies a voltage between a transparent electrode layer of the electro-optic modulator and a plurality of pixel electrodes, and a reflected light sensor that measures light reflected from the electro-optic modulator.